Objective-To better understand the mechanism of platelet recruitment and activation by Streptococcus gordonii. The oral bacterium Streptococcus gordonii, is amongst the most common pathogens isolated from Infective Endocarditis patients, and has the property of being able to activate platelets, leading to thrombotic complications. The mechanism of platelet recruitment and activation by S. gordonii is poorly understood. Methods and Results-Infective endocarditis is a bacterial infection of the heart valves that carries a high risk of morbidity and mortality. The oral bacterium, S gordonii, is among the most common pathogens isolated from patients with infective endocarditis and is able to activate platelets, leading to thrombotic complications. Platelets interact with S gordonii via glycoprotein Ib␣-and ␣ IIb ␤ 3 -recognizing S gordonii surface proteins haemaglutitin salivary antigen (Hsa) and platelet adherence protein A, respectively. The inhibition of glycoprotein Ib␣ or ␣ IIb ␤ 3 using blocking antibodies or deletion of S gordonii Hsa or platelet adherence protein A significantly reduces platelet adhesion. 
I
nfective endocarditis (IE) is considered to be the fourth leading cause of life-threatening infectious disease and is associated with significant morbidity and mortality. 1 It typically develops in individuals with an underlying cardiac defect and usually occurs in close proximity to lesions subjected to hemodynamic disturbance. 2 These lesions have the ability to generate turbulent blood flow, which, in turn, can damage the endothelial surface, exposing the subendothelial matrix. This area becomes highly thrombogenic, leading to platelet deposition and the formation of a fibrin network. 3 This sterile platelet fibrin nidus, in turn, recruits bacteria from either a distal source or a focal infection resulting from transient bacteremia. 4, 5 Finally, secondary accumulation of platelets encases the bacteria forming a septic thrombus. 6 Thrombus formation may lead to aortic valve leaflet perforation that can manifest itself as acute congestive heart failure. 7 The American Heart Association 1 has recently issued evidence-based guidelines for the treatment of IE, which consist of aggressive antibiotic therapy. However, this approach is often less than optimal; even with treatment, the mortality rate can be as high as 36%, 8 perhaps because of the fact that significant levels of antibiotic fail to penetrate the growing thrombus.
The viridans group of streptococci is responsible for 44% of IE cases. 9 Streptococcus gordonii is a member of the viridans group and an oral bacterium that resides primarily in dental plaque on the tooth surface. 10, 11 Chronic oral disease, such as periodontitis, or dental manipulation provides a route of entry of bacteria into the circulation, leading to transient bacteremia. 12 Streptococcus gordonii is well-known for its ability to interact with human blood platelets, 13 and this may be an important contributor for the initiation of IE.
A picture demonstrating the complexity of the interactions between S gordonii and platelets is starting to unfold in the literature. 13 It is well established that multiple strains of streptococci can induce platelet aggregation and support platelet adhesion. 14 -16 Recently, it was demonstrated that under low shear conditions, platelets are capable of rolling along immobilized S gordonii in a manner similar to platelet rolling on immobilized von Willebrand factor at sites of vascular injury. 15 Platelet rolling on immobilized S gordonii results in firm adhesion. Streptococcus gordonii express 2 large highly glycosylated proteins, glycosylated streptococcal protein B (GspB) and Hsa, that bind specifically to N-linked sialic acid residues on glycoprotein (GP) Ib␣ 17 ; these interactions are believed to mediate platelet rolling. Inactivation of the hsa gene in S gordonii-ablated platelet rolling. 15 More recently, researchers identified another large protein expressed on S gordonii, platelet adherence protein A (PadA, 397 kDa). This protein specifically binds to the major platelet integrin, ␣ IIb ␤ 3 . Disruption of the padA gene significantly reduced platelet adhesion to S gordonii. 16 Therefore, platelet adhesion to S gordonii is a multifactorial event in which Hsa binds to GPIb␣, mediating platelet rolling; and PadA binds to ␣ IIb ␤ 3 , mediating firm adhesion. Together, these proteins act synergistically to recruit and activate platelets on the bacterial surface.
Ligand binding to platelet surface receptors results in the generation of outside-in signals that initiate a series of cytosolic changes that promote spreading. This spreading is essential for the platelet to withstand the shear forces experienced in the vasculature. Recently, Boylan et al 18 demonstrated that the ITAM-bearing receptor, Fc␥RIIa, functions as a key component of outside-in signal amplification mediated by ␣ IIb ␤ 3 . This study was undertaken to determine whether platelet interactions with S gordonii result in similar outside-in amplification signals, leading to platelet spreading. Our findings have important implications for understanding the molecular mechanisms through which the platelet response to bacteria contributes to the development of a thrombus in patients with IE. Understanding these mechanisms may lead to the development of novel therapeutic agents to treat this disease.
Methods

Antibodies and Reagents
The following items were purchased commercially: anti-Syk (clone D-3) and anti-PLC␥2 (clone B-10) and polyclonal anti-Fc␥RIIa (clone C-17) antibodies; antibodies detecting tyrosine-phosphorylated Syk (tyrosine 525/526) and PLC␥2 (tyrosine 759); the anti-phosphotyrosine monoclonal antibody, 4G10; monoclonal anti-Fc␥RIIa antibody, IV.3; integrin pepidomimetic H-Arg-Gly-Asp-Ser-OH (RGDS); monoclonal antibody abciximab; MB45 19 ; brain heart infusion and M17 media; and all other laboratory reagents. Monovalent antigen-binding fragments (Fabs) were prepared from monoclonal antibody (mAb) IV.3 using an Fab preparation kit.
Bacterial Strains and Growth Conditions
Sources and strains of S gordonii used in this study are listed in the supplemental Table (available online at http://atvb.ahajournals.org). Deletion of hsa or padA in S gordonii DL1 by allelic exchange mutagenesis has been described previously. 16, 20 Streptococcus gordonii strains were maintained on blood agar and subsequently grown in brain heart infusion (BHI) broth in sealed tubes incubated statically overnight (stationary phase) at 37°C for use in experiments. For all experiments, S gordonii suspensions were adjusted to 1ϫ10 9 cells/mL for platelet adhesion/spreading studies.
Platelet Preparation
Whole blood was drawn from the antecubital vein of healthy volunteers who had abstained from taking nonsteroidal antiinflammatory drugs in the previous 10 days. Informed consent was obtained from all subjects. Nine volumes of blood were added to one volume of acid-citrate-dextrose. Platelet-rich plasma and gel-filtered platelets were prepared as previously described. 13 
Static Platelet Adhesion Assay
Static platelet adhesion was measured as previously described. 15 Briefly, 96-well microtiter plates were coated with 100 L of bacteria (1ϫ10 9 cells/mL), fibrinogen (20 g/mL), or 1% BSA. Gel-filtered platelets (2ϫ10 8 platelets/mL) were added to each well and allowed to adhere for 45 minutes at 37°C. Adherent platelets were then lysed with lysis buffer containing a substrate for acid phosphatase and incubated for 20 minutes at 37°C. The resultant color was read at 410 nm in a microtiter plate reader (Wallac Victor2). In some experiments, gel-filtered platelets were preincubated with specific monoclonal antibody for 15 minutes before addition to bacteria-coated wells.
Platelet Spreading on Immobilized Bacteria
Poly-L-lysine-coated glass slides were coated with human fibrinogen (50 g/mL) or S gordonii (1ϫ10 9 cells/mL) overnight at 4°C. Slides were then blocked with 1% BSA for 2 hours at 37°C and finally washed with Tris-buffered saline to remove any unbound BSA. Gel-filtered platelets (5ϫ10 6 platelets/mL) were preincubated with inhibitors (abciximab, 50 g/mL; RGDS, 10 mmol/L; apyrase, 2 U/mL; or anti-Fc␥RIIa mAb IV.3, 1 g/mL) for 15 minutes at room temperature and then allowed to spread on either fibrinogen or S gordonii for 60 minutes. After gently rinsing 3 times with modified HEPES-Tyrodes buffer, spread platelets were fixed with 3.7% paraformaldehyde for 10 minutes at room temperature and permeabilized in ice-cold acetone for 5 minutes. Platelets were stained using phalloidin (Alexa 546) for 20 minutes at room temperature in the dark. Samples were mounted in mounting media (Vectashield), and images were acquired (ϫ63) using a confocal microscope (Zeiss LSM 510) in differential interference contrast or using an argon laser at 488 nm.
Dense Granule Secretion
Dense granule secretion was measured by luminometry using a luciferin/luciferase assay. Platelets (2ϫ10 8 /mL) were incubated with PBS (as control), RGDS (10 mmol/L), abciximab (10 g/mL), IV.3 (5 g/mL), or apyrase (2 U/mL) for 10 minutes at room temperature. Chronolume luciferin/luciferase mix was added, and luminescence was read in a microtiter plate reader.
Western Blotting and Immunoprecipitation
Gel-filtered platelets (1ϫ10 9 /mL) that adhered to either immobilized fibrinogen or S gordonii, in the presence or absence of an Fab fragment of IV.3, were lysed using a buffer (ϫ2 Nonidet-P40) containing a protease inhibitor cocktail and phosphatase inhibitors (sodium fluoride and sodium orthovanadate). A small aliquot was dissolved with SDS sample buffer for detection of total phosphorylation. A monoclonal antibody specific for Fc␥RIIa, IV.3, was added to the resultant supernatant and incubated overnight. Fc␥RIIa was immunoprecipitated by the addition of protein G cross-linked agarose (Sepharose). Cleared lysates were separated by SDS-PAGE, transferred to polyvinylidene fluoride, and blocked with BSA in 0.5% Tris-buffered saline Tween for 60 minutes. Immunoprecipitated immunoblots were stained with antibodies specific for tyrosinephosphorylated Syk and tyrosine-phosphorylated PLC␥2. The antiphosphotyrosine monoclonal antibody 4G10 was used to detect immunoprecipitated phosphorylated Fc␥RIIa. Equal loading was detected using antibodies against Syk, PLC␥2, and Fc␥RIIa. Protein bands were detected using species-specific horseradish peroxidaseconjugated secondary antibody and chemiluminescence.
Statistical Analysis
Statistics were performed using statistical software (InStat). Data shown are the meanϮSEM, and comparisons between mean values were performed using the Student paired or unpaired t test.
Results
Platelet Adhesion to Immobilized S gordonii Is Mediated by Platelet Membrane Receptors ␣ IIb ␤ 3 and GPIb␣ and S gordonii Surface Proteins PadA and Hsa
Previous studies have shown that PadA and Hsa are important mediators of platelet adhesion to S gordonii. 16 As shown in Figure 1A , deletion of the gene encoding either protein significantly reduced platelet adhesion; however, deletion of genes encoding both proteins had no additional effect. In contrast, deletion of the streptococcal salivary protein (ssp)-A and sspB genes, the products of which are known to play an important role in S gordonii-induced platelet aggregation, had no significant effect on platelet adhesion. Platelet adhesion to S gordonii was significantly inhibited by the anti-␣ IIb ␤ 3 antibody, abciximab, or the anti-GPIb␣ antibody, MB45, but not by a control antibody ( Figure 1B ). These data demonstrate that neither ␣ IIb ␤ 3 /PadA nor GPIb␣/Hsa interactions by themselves are sufficient to support platelet adhesion because residual adhesion can still be observed in the absence of both of these interactions, therefore suggesting that another, as yet uncharacterized, interaction exists between S gordonii and platelets.
Platelet Adhesion to Immobilized S gordonii Leads to the Generation of an Outside-In Signal That Initiates Full Platelet Spreading
When platelets adhere to fibrinogen, a ligand-binding-induced ␣ IIb ␤ 3 -mediated signal is generated, leading to platelet spreading that enables adherent platelets to resist the shear forces at the site of vascular injury. 3 To investigate whether platelets adherent to S gordonii were capable of spreading in a similar manner, platelets were allowed to adhere to BSA, fibrinogen, or S gordonii; and spreading was evaluated by differential interference contrast and immunofluorescence microscopy. To analyze the percentage of platelets spread, we randomly selected 5 areas containing 200 or more total cells.
The percentage of platelets spread was calculated as a fraction of total platelets. Consistent with previous results, platelets failed to spread on BSA but spread on immobilized fibrinogen ( Figure 2 ). Platelet spreading on wild-type S gordonii, as defined by evidence of pseudopod and lamellipod formation, occurred within 15 minutes. The morphological features of platelets spread on S gordonii at 15 minutes resembled those of platelets spreading on fibrinogen at 15 minutes.
Because S gordonii surface proteins PadA and Hsa are important in supporting platelet adhesion, we next investigated whether these proteins contributed to platelet spreading. Deletion of the ␣ IIb ␤ 3 ligand, PadA, from S gordonii abolished platelet spreading, showing little or no signs of cytoskeletal rearrangements; however, deletion of Hsa failed to have any effect on platelet spreading (Figure 2 ). Deletion of both PadA and Hsa together also ablated platelet spreading, similar to that seen with the ⌬padA alone. These data suggest that, although both ␣ IIb ␤ 3 /PadA and GPIb␣/Hsa interactions contribute to platelet adhesion on immobilized S gordonii, ␣ IIb ␤ 3 /PadA interactions are the major contributor to outside-in signaling, leading to platelet activation and spreading.
To confirm the importance of ␣ IIb ␤ 3 in platelet spreading on S gordonii, platelets were pretreated with either an inhibitory peptide mimetic for the common integrin recognition motif, RGDS, or the ␣ IIb ␤ 3 -specific monoclonal anti- body, abciximab. As shown in Figure 3 , each of these significantly inhibited platelet spreading on fibrinogen and S gordonii. Platelet adhesion to fibrinogen or S gordonii was unaffected when pretreated with ADP scavenger, apyrase (2%Ϯ1% inhibition of platelet adhesion to fibrinogen in the presence of apyrase and 0% inhibition of platelet adhesion to S gordonii in the presence of apyrase; Pϭ0.195; nϭ6). Platelets, however, failed to spread on fibrinogen or S gordonii in the presence of apyrase, suggesting that platelet adhesion to fibrinogen or S gordonii stimulated the release of small potentiating amounts of ADP into the local platelet environment. Taken together, these data confirm the importance of ␣ IIb ␤ 3 in S gordonii-induced platelet activation, leading to cytoskeletal rearrangements, granule secretion, and platelet spreading.
Platelet Spreading on S gordonii Requires an
The exact mechanism by which integrins promote outside-in signals is not fully understood; however, several lines of evidence suggest that ITAM-bearing receptors function to amplify integrin-mediated cellular activation, 21 including the recently described ␣ IIb ␤ 3 /Fc␥RIIa integrin/ITAM cluster that is expressed on platelets. 18 When incubated with a small Fab fragment derived from the anti-Fc␥RIIa-specific monoclonal antibody, IV.3, platelets failed to spread on immobilized fibrinogen ( Figure 3A and 3C) or S gordonii ( Figure 3B and 3C). Platelet adhesion to fibrinogen or S gordonii was unaffected in the presence of mAb IV.3, (3.0%Ϯ0.5% inhibition of platelet adhesion to fibrinogen in the presence of IV.3 and 0% inhibition of platelet adhesion to S gordonii in the presence of IV.3; Pϭ0.945; nϭ5), suggesting that platelet Fc␥RIIa does not mediate platelet S gordonii interactions; rather, it amplifies the outside-in signaling after engagement of ␣ IIb ␤ 3 with PadA on S gordonii. Moreover, preincubating gel-filtered platelets with mAb IV.3 abolishes S gordoniiinduced platelet aggregation (56%Ϯ1% untreated versus 5%Ϯ2% IV.3 treated; PϽ0.0001), further demonstrating the role of Fc␥RIIa for relaying ␣ IIb ␤ 3 -mediated signals into the platelet.
Platelet-Dense Granule Secretion Is Both Induced by and Contributes to Platelet Spreading on S gordonii
The observation that apyrase had no effect on platelet adhesion, but rather inhibited subsequent platelet spreading (Figure 3 ), suggested that platelet/S gordonii interactions initiated by PadA binding to ␣ IIb ␤ 3 /Fc␥RIIa induced the release of ADP from platelet-dense granules. ATP also exists in the dense granules and is often used as a measure of dense granule release. Therefore, to determine whether S gordonii induces platelet secretion, platelets were allowed to adhere to immobilized bacteria, and ATP release was measured in a luminescence assay. As shown in Figure 4 , platelets bound to S gordonii exhibited secretion similar to that induced by thrombin receptor activating peptide (TRAP). Granule release was significantly reduced when platelets were preincubated with mAb, IV.3, consistent with the notion that ␣ IIb ␤ 3 / Fc␥RIIa mediates platelet activation induced by S gordonii. Integrin-mediated platelet adhesion to immobilized ligands results in the generation of outside-in signals that lead to tyrosine phosphorylation of numerous signaling molecules. 22 To confirm biochemically that Fc␥RIIa acts as an amplifier of integrin signaling when platelets adhere to S gordonii, we allowed platelets to spread on immobilized wild-type S gordonii and assessed the tyrosine phosphorylation state of Fc␥RIIa and its key downstream regulators, Syk and PLC␥2. As shown in Figure 5A , platelet spreading on S gordonii led to phosphorylation of Fc␥RIIa, Syk, and PLC␥2. Furthermore, preincubation of platelets with Fab IV.3 before adhesion on either fibrinogen or S gordonii abolished phosphorylation of Fc␥RIIa ( Figure 5B ). Taken together with the observation that mAb IV.3 prevents platelet spreading on S gordonii, these data demonstrate that after adhesion to S gordonii, Fc␥RIIa plays an essential role in transducing signals that mediate platelet spreading.
Discussion
The viridans group of streptococci is a major constituent of supragingival and subgingival dental plaque. 10, 23 They exist in the oral cavity as harmless commensals; however, when they gain entry to the circulation, they behave as pathogens. Severe oral disease or dental manipulation provides a route of entry for these bacteria to the blood. Once in the blood, they interact with circulating platelets to initiate inappropriate thrombus formation. Thrombus formation is thought to play a critical role in IE. 24 IE describes a family of persistent microbial infections that typically target previously damaged or diseased heart valves. 6 Streptococcus gordonii is a prominent member of the viridans group of streptococci and is commonly isolated from patients presenting with IE. The ability of S gordonii to activate platelets is considered a primary event in the pathogenesis of IE and the severity of the clinical signs. 6 Many attempts have been made to understand the mechanisms through which S gordonii can bind to platelets and generate an intracellular signal leading to thrombus formation in vitro. Recently, a model of the early stages of infection was proposed, in which platelets roll along immobilized S gordonii using an interaction that involves platelet GPIb␣ interacting with S gordonii surface protein Hsa. 15 This rolling interaction slows platelets sufficiently to allow a second interaction between platelet ␣ IIb ␤ 3 and S gordonii PadA, resulting in firm adhesion. 16 Even though S gordonii is not a natural ligand for platelets, this proposed model suggests that bacterial deposition on damaged endothelium mimics the platelet response to vascular injury.
In the present study, we demonstrated that on firm adhesion to immobilized S gordonii, platelets receive a signal that leads to extension of filopodia and lamellipodia with controlled orientation of stress fibers leading to full platelet spreading. Platelet spreading reflects the ability of ␣ IIb ␤ 3 to bind PadA on the surface of S gordonii. Disruption of the padA gene abolishes platelet spreading, whereas disruption of the hsa gene has no effect (Figure 2 ). The function of platelet spreading is essential for the platelet to withstand the shear forces experienced in the vasculature. Spreading is a particularly important step in the development of thrombotic vegetations in IE because shear forces around the lesion on the cardiac valve are often turbulent. 2 Therefore, platelets Figure 4 . Streptococcus gordonii induces dense granule secretion from platelets. Dense granule release was inhibited by preincubating platelets with either IV.3 (5 g/mL) or apyrase (2 U/mL). Dense granule release was measured using a chronolume luciferin/luciferase mix and was read in the luminescence channel in a microtiter plate reader. *PϽ0.01. require the conversion from a discoid shape to a fully spread cell to withstand turbulent shear force.
Platelet spreading is mediated by a signal generated as a result of ligand binding through a process called outside-in signaling. The best-characterized outside-in signal in platelets is that mediated by ␣ IIb ␤ 3 . 22, [25] [26] [27] Outside-in signaling through ␣ IIb ␤ 3 on a vascular matrix of fibrinogen or immobilized von Willebrand factor plays a critical role in mediating platelet spreading. 25, 28 ␣ IIb ␤ 3 can bind several macromolecular adhesive GPs that contain the short amino acid sequence RGD. 29 There are several sites on fibrinogen that bind to ␣ IIb ␤ 3. These include the widely studied RGD site found twice on the A␣ chain 30 and a carboxyterminal dodecapeptide (HHLGGAKQAGDV) found on the ␥ chain. 31 Previously, we demonstrated that an N-terminal PadA recombinant polypeptide bound to platelets in an ␣ IIb ␤ 3 -dependent manner. 16 Moreover, wild-type S gordonii expressing PadA but not S gordonii defective in PadA expression could bind to purified ␣ IIb ␤ 3 and Chinese hamster ovary cells stably transfected with ␣ IIb ␤ 3 . Together, these results suggest that PadA binding to the platelet generates an outside-in signal through ␣ IIb ␤ 3 to mediate spreading. Streptococcus gordonii defective in PadA expression failed to spread after 60 minutes, suggesting that kinetics is not a factor because platelets were spread on wild-type S gordonii after 15 minutes, similar to the time to platelet spreading on immobilized fibrinogen. Platelet spreading on immobilized fibrinogen or S gordonii is abolished when platelets are preincubated with abciximab or a short peptide-containing peptide RGDS ( Figure  3 ). These results suggest that ␣ IIb ␤ 3 might bind S gordonii through an RGD-like sequence on PadA. Protein analysis identified 2 potential RGD-like regions (RGG and RGT) and a dodecapeptidelike region (AGD) that may act as binding sites for ␣ IIb ␤ 3 on the N-terminus fragment of PadA.
There is a considerable body of evidence that concomitant granular secretion of ADP from adherent platelets is necessary for full platelet spreading. 32, 33 Consistent with these results, we found that preincubation of platelets with the ADP scavenger apyrase prevented platelet spreading on fibrinogen and immobilized S gordonii (Figure 3) . Therefore, it is likely that platelet adhesion and spreading on S gordonii stimulate the release of potentiating amounts of ADP into the local platelet milieu, facilitating the cytoskeletal rearrangements necessary for platelet spreading.
The presence of an Fc receptor on platelets has attracted much attention recently because numerous reports suggest that platelets may play a role in host defense by recognizing antibody-bound foreign invaders. 13 Youssefian et al 34 reported that platelets can actively phagocytose IgG-bound Staphylococcus aureus; however, whether platelets have the ability to destroy the bacteria once phagocytosed is still questionable. Other reports suggest that antibody binding to bacteria is essential for triggering platelet activation. For example, Streptococcus sanguinis strain 2017 to 78 triggers platelet activation in an antibody-dependent manner. The inhibition of Fc␥RIIa, using mAb IV.3, prevented this platelet activation. 35 In addition, S aureus strain Newman surface protein, clumping factor A, requires binding of IgG and fibrinogen to trigger aggregate formation under conditions of high shear. Blocking Fc␥RIIa prevented aggregate formation; however, it failed to prevent single-platelet adhesion. 36 Although there is little doubt that antibody binding to bacteria is essential for triggering platelet activation/aggregation, this appears be strain or species specific. For example, in this report, we demonstrate that S gordonii can induce platelet aggregation in an antibody-free environment and that aggregation can be abolished by blocking Fc␥RIIa. We have also shown this to be true for several other strains of streptococci capable of inducing platelet aggregation, including S sanguinis strain SK34 and Streptococcus pneumoniae strain IO1196. 37 Fc␥RIIa is a member of the immunoglobulin gene superfamily and is the most widely distributed Fc␥ receptor in nature. 38 It is expressed on neutrophils, monocytes, macrophages, and platelets. 39 It is capable of functioning as a low-affinity IgG receptor with approximately 2000 to 3000 copies per platelet. 40 -42 It consists of a single transmembrane domain, a C-terminal that contains the binding site for IgG, and a cytoplasmic domain. The cytoplasmic domain contains 2 YXXL sequences separated by 12 amino acids that together constitute its ITAM domain. 43 Significant emphasis has been placed on the importance of ITAM-containing receptors as signal amplifiers in various cell types. Researchers 21, 44 demonstrated that the ␤ 2 integrin in neutrophils and monocytes requires tyrosine phosphorylation of the ITAM-containing adapter molecules, FcR␥ or DAP12, to trigger an intracellular signal; and that there are more articles in the literature describing the importance of ITAM-bearing receptors in platelet signaling. Previous studies 45, 46 demonstrated that GPVI, a receptor for collagen, associates with FcR␥, which triggers platelet activation through Src kinases and Syk. C-type lectin receptor 2 (CLEC-2) is a newly discovered ITAM receptor on platelets. On binding the toxin rhodocytin, the ITAM region of CLEC-2 becomes phosphorylated, triggering activation of downstream effectors, such as Syk, Brutons tyrosine kinase, linker for activation of T-cells LAT, Src homology 2(SH2) domain-containing leukocyte protein of 76-kDa (SLP)-76, and PLC␥2. [47] [48] [49] More recently, an article by Boylan et al 18 demonstrated that Fc␥RIIa plays a key role in the outside-in signal mediated by ␣ IIb ␤ 3 on binding to either soluble or immobilized fibrinogen. In our experiments, platelet spreading on S gordonii leads to phosphorylation of the tyrosine residues on Fc␥RIIa. This, in turn, mediates the activation of downstream regulators Syk and PLC␥2. Inhibition of Fc␥RIIa prevents tyrosine phosphorylation, resulting in inhibition of platelet-dense granule secretion, filopodial and lamellipodial extension, and platelet spreading.
The involvement of Fc␥RIIa in mediating both platelet activation and spreading in response to S gordonii makes it a potential target for therapeutic intervention. The inhibition of this receptor, although not treating the infection, would prevent the potentially fatal thrombotic complications of S gordonii infection without compromising normal platelet function. Novel drug therapies could be used in conjunction with antibiotics to treat IE or on their own as a prophylaxis for high-risk patients. 
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